HLN – Haleon plcHLN
Haleon plcHLN
$9.68Name : Haleon plc
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $43,308,187,648.00
EPSttm : 0.44
Haleon plc
$9.68
0.89%$0.085Float Short %
0.2
Margin Of Safety %
Put/Call OI Ratio
0.12
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
9.59
Target Price
10.93
Analyst Recom
2
Performance Q
-0.93
Relative Volume
1.28
Beta
0.18
Ticker: HLN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | HLN | 9.41 | 0.12 | 0.37 | 3456 |
| 2025-10-21 | HLN | 9.33 | 0.12 | 0.00 | 3445 |
| 2025-10-22 | HLN | 9.44 | 0.12 | 0.22 | 3449 |
| 2025-10-23 | HLN | 9.36 | 0.12 | 0.40 | 3456 |
| 2025-10-24 | HLN | 9.24 | 0.12 | 0.30 | 3458 |
| 2025-10-27 | HLN | 9.18 | 0.12 | 1.33 | 3462 |
| 2025-10-28 | HLN | 9.1 | 0.12 | 999.99 | 3466 |
| 2025-10-29 | HLN | 9.03 | 0.12 | 0.00 | 3466 |
| 2025-10-30 | HLN | 9.19 | 0.12 | 0.20 | 3481 |
| 2025-10-31 | HLN | 9.28 | 0.12 | 0.00 | 3482 |
| 2025-11-03 | HLN | 9.4 | 0.12 | 0.12 | 3485 |
| 2025-11-04 | HLN | 9.34 | 0.12 | 0.00 | 3386 |
| 2025-11-05 | HLN | 9.31 | 0.12 | 0.00 | 3396 |
| 2025-11-06 | HLN | 9.43 | 0.12 | 0.00 | 3458 |
| 2025-11-07 | HLN | 9.47 | 0.12 | 0.29 | 3472 |
| 2025-11-10 | HLN | 9.58 | 0.12 | 0.16 | 3471 |
| 2025-11-11 | HLN | 9.86 | 0.12 | 0.01 | 3421 |
| 2025-11-12 | HLN | 9.89 | 0.11 | 0.02 | 3643 |
| 2025-11-13 | HLN | 9.9 | 0.11 | 0.56 | 3621 |
| 2025-11-14 | HLN | 9.58 | 0.12 | 0.05 | 3706 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | HLN | 9.41 | - | - | - |
| 2025-10-21 | HLN | 9.33 | - | - | - |
| 2025-10-22 | HLN | 9.45 | - | - | - |
| 2025-10-23 | HLN | 9.37 | - | - | - |
| 2025-10-24 | HLN | 9.24 | - | - | - |
| 2025-10-27 | HLN | 9.18 | - | - | - |
| 2025-10-28 | HLN | 9.12 | - | - | - |
| 2025-10-29 | HLN | 9.03 | - | - | - |
| 2025-10-30 | HLN | 9.18 | - | - | - |
| 2025-10-31 | HLN | 9.27 | - | - | - |
| 2025-11-03 | HLN | 9.40 | - | - | - |
| 2025-11-04 | HLN | 9.34 | - | - | - |
| 2025-11-05 | HLN | 9.31 | - | - | - |
| 2025-11-06 | HLN | 9.43 | - | - | - |
| 2025-11-07 | HLN | 9.46 | - | - | - |
| 2025-11-10 | HLN | 9.57 | - | - | - |
| 2025-11-11 | HLN | 9.85 | - | - | - |
| 2025-11-12 | HLN | 9.88 | - | - | - |
| 2025-11-13 | HLN | 9.90 | - | - | - |
| 2025-11-14 | HLN | 9.59 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | HLN | 0 | -1.09 | 0.25 |
| 2025-10-21 | HLN | 0 | -1.09 | 0.25 |
| 2025-10-22 | HLN | 0 | -1.09 | 0.25 |
| 2025-10-23 | HLN | 0 | -1.09 | 0.25 |
| 2025-10-24 | HLN | 0 | -1.09 | 0.25 |
| 2025-10-27 | HLN | 0 | 0.77 | 0.20 |
| 2025-10-28 | HLN | 0 | 0.77 | 0.20 |
| 2025-10-29 | HLN | 0 | 0.77 | 0.20 |
| 2025-10-30 | HLN | 0 | 0.77 | 0.20 |
| 2025-10-31 | HLN | 0 | 0.77 | 0.20 |
| 2025-11-03 | HLN | 0 | -14.49 | 0.20 |
| 2025-11-04 | HLN | 0 | -14.49 | 0.20 |
| 2025-11-05 | HLN | 0 | -14.49 | 0.20 |
| 2025-11-06 | HLN | 0 | -14.49 | 0.20 |
| 2025-11-07 | HLN | 0 | -14.49 | 0.20 |
| 2025-11-10 | HLN | 0 | -14.63 | 0.20 |
| 2025-11-11 | HLN | 0 | -14.63 | 0.20 |
| 2025-11-12 | HLN | 0 | -14.63 | 0.20 |
| 2025-11-13 | HLN | 0 | -14.63 | 0.20 |
| 2025-11-14 | HLN | 0 | -14.63 | 0.20 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-14.63
Beta
0.18
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
Growth Score
22
Sentiment Score
81
Actual DrawDown %
16
Max Drawdown 5-Year %
Target Price
10.93
P/E
22.16
Forward P/E
17.88
PEG
2.38
P/S
3
P/B
1.97
P/Free Cash Flow
16.64
EPS
0.43
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
13.81
Relative Volume
1.28
Return on Equity vs Sector %
Return on Equity vs Industry %
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Haleon plcSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 24561
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
stock quote shares HLN – Haleon plcHLN Stock Price stock today
news today HLN – Haleon plcHLN stock forecast ,stock prediction 2023 2024 2025
marketwatch HLN – Haleon plcHLN yahoo finance google finance
stock history HLN – Haleon plcHLN invest stock market
stock prices HLN premarket after hours
ticker HLN fair value insiders trading